Sat.Nov 13, 2021 - Fri.Nov 19, 2021

article thumbnail

FDA clears GE Healthcare AI algorithm for patient intubation

pharmaphorum

An artificial intelligence algorithm developed by GE Healthcare that helps with the placement of endotracheal tubes (ETTs) has been approved by the FDA. The new tool – part of GE’s Critical Care Suite 2.0 – helps bedside staff and radiologists assess patients before intubation – for example prior to ventilation in patients with critical COVID-19 – and make sure their ETTs are positioned correctly.

FDA 145
article thumbnail

SCAN launches in-home, virtual primary care medical group

Fierce Healthcare

SCAN launches in-home, virtual primary care medical group. pminemyer. Wed, 11/17/2021 - 16:03.

144
144
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Pfizer inks COVID-19 treatment licensing agreement with MPP

Outsourcing Pharma

The pact between the drug firm and the group is aimed at giving equitable access to treatments and vaccines for people in disadvantaged parts of the world.

article thumbnail

Report: UK disposed of 600,000 AZ vaccine doses after they passed expiry date

Pharma Times

The data was obtained by a Freedom of Information request, according to The Independent

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Boost for Amazon’s telehealth business, as Hilton signs up

pharmaphorum

Amazon’s push into the provision of remote healthcare services has been rewarded with a top-tier corporate client – the Hilton hotel chain. The deal – first reported by Reuters – involves the Amazon Care platform, which includes remote, online consultations with clinicians, as well as home visits in some areas. It provides primary and preventive care, ongoing support for chronic conditions, and referrals to secondary and tertiary care.

Hospitals 133
article thumbnail

Medicare startup EasyHealth gets $135M in series A to fill information gaps

Fierce Healthcare

Medicare startup EasyHealth gets $135M in series A to fill information gaps. rtorrence. Fri, 11/19/2021 - 10:10.

143
143

More Trending

article thumbnail

A new way to access scientific papers?

Fierce Pharma

A new way to access scientific papers? admin. Mon, 11/15/2021 - 12:01.

59
article thumbnail

AZ, Moderna say mRNA drug is promising in heart failure

pharmaphorum

Moderna is already riding high on the strength of its mRNA-based COVID-19 vaccine, but the broader potential of its technology has been shown in a new AstraZeneca-partnered candidate for heart failure. At the American Heart Association (AHA) congress, the two partners presented results from the phase 2a EPICCURE trial that showed that injecting their AZD8601 candidate directly into the heart muscle of patients undergoing coronary artery bypass graft (CABG) surgery seemed to improve heart functio

Vaccines 130
article thumbnail

MedArrive nabs $25M to ramp up at-home health services, expand into new states

Fierce Healthcare

MedArrive nabs $25M to ramp up at-home health services, expand into new states. hlandi. Fri, 11/19/2021 - 16:56.

141
141
article thumbnail

More sites and sponsors betting on decentralized format: Science 37

Outsourcing Pharma

According to data released by the company, the majority of study professionals plan to run agile or hybrid trials over the course of the next 12 months.

82
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Under-18s with COVID-19 in UK advised to wait 12 weeks for vaccine dose

Pharma Times

The UKHSA have said that deferring the vaccine dose could help to reduce even further the small risk of heart inflammation following vaccination

article thumbnail

Respira Labs’ wearable device listens for lung diseases

pharmaphorum

US company Respira Labs has developed a device worn on the chest that uses tiny speakers and microphones to project sound into the lungs and listen for signals that could indicate serious lung diseases. The Sylvee wearable uses an artificial intelligence (AI) algorithm to interpret sounds that may indicate trapped air in the lungs, which can be a sign of ill health, using acoustic resonance – similar to the way an ultrasound machine creates visual images.

Hospitals 122
article thumbnail

Nursing startup nabs $149M for healthcare staffing platform

Fierce Healthcare

Nursing startup nabs $149M for healthcare staffing platform. rtorrence. Thu, 11/18/2021 - 12:23.

138
138
article thumbnail

Biohaven wraps patient enrollment for ALS clinical trial arm

Outsourcing Pharma

The pharma company has completed enrollment of amyotrophic lateral sclerosis patients in its study investigating drugs like verdiperstat, an oral treatment.

69
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

MHRA authorises Vumerity for multiple sclerosis patients

Pharma Times

Vumerity is a next-generation oral fumarate treatment for adults with relapsing-remitting multiple sclerosis

54
article thumbnail

Parliamentary probe finds racism evidence in NHS sickle cell care

pharmaphorum

Patients with sickle cell disease are facing racism in the NHS that is putting their lives a risk, claims a new report. . The All-Party Parliamentary Group (APPG) document – entitled No One’s Listening and partnered with the Sickle Cell Society – found “serious care failings” in acute services and evidence of attitudes underpinned by racism in the care of people with SCD, a red blood cell disorder that mainly affects black people.

article thumbnail

Healthfirst releases road map to addressing health equity, gaps in care

Fierce Healthcare

Healthfirst releases road map to addressing health equity, gaps in care. pminemyer. Wed, 11/17/2021 - 13:37.

138
138
article thumbnail

WHY PM MODI ADDRESSED, INDIA AS THE PHARMACY OF THE WORLD

Pharma Tutor

WHY PM MODI ADDRESSED, INDIA AS THE PHARMACY OF THE WORLD. Recently, during inauguration of Global Innovation Summit of the pharmaceuticals sector Indian Prime Minister Shri Narendra Modi addressed, India as the Pharmacy of the world. He said that our definition of wellness is not limited by physical boundaries. We have exported life-saving medicines and medical equipment to over 150 countries during the initial phase of the pandemic.

article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Vertex receives CHMP positive opinion for Kaftrio in children with cystic fibrosis

Pharma Times

Those eligible will have at least one F508del mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene

54
article thumbnail

Smartphone-powered trial backs J&J’s Invokana for heart failure

pharmaphorum

Johnson & Johnson’s SGLT2 inhibitor Invokana has been shown to have a significant effect on heart failure symptoms in a clinical trial that relied entirely on remote monitoring of symptoms using a smartphone app. The real-world CHIEF-HF study is said to be the first fully “decentralised, mobile, indication-seeking clinical study” with no need for patients to visit clinic, according to J&J’s pharma division Janssen.

Labelling 105
article thumbnail

Cigna study: How much behavioral health treatment can lower total cost of care

Fierce Healthcare

Cigna study: How much behavioral health treatment can lower total cost of care. pminemyer. Tue, 11/16/2021 - 10:37.

137
137
article thumbnail

Global pharma industry gathers at CPhI Worldwide 2021 as surge in partnering expected in 2022

Pharma Mirror

Amsterdam, CPhI Worldwide (9-11 November, 2021), which held its first in-person event since 2019, hosted the global pharma community at the Fiera Milano, Milan, welcoming exhibitors and attendees from 146 countries. This year’s smart event was a combination of a three-day live exhibition, and a month-long online event featuring both the latest market insights through live and on demand content sessions and of course networking opportunities.

52
article thumbnail

NICE recommends Inrebic for rare blood cancer

Pharma Times

Eligible adult patients with primary or secondary myelofibrosis will now be able to access the treatment on the NHS

54
article thumbnail

In shock move, Biogen chief medical officer Al Sandrock will stand down

pharmaphorum

Biogen’s chief medical officer Al Sandrock has announced he will retire at the end of the year, ending a 23-year career at the biotech. The architect of many of Biogen’s biggest-selling drugs, Sandrock is bowing out as Biogen is still struggling with the rollout of its controversial new Alzheimer’s disease therapy Aduhelm (aducanumab).

FDA 105
article thumbnail

Experts weigh in on ways to combat growing antibiotic resistance amid COVID-19

Fierce Healthcare

Experts weigh in on ways to combat growing antibiotic resistance amid COVID-19. agliadkovskaya. Thu, 11/18/2021 - 15:20.

136
136
article thumbnail

China sees huge bounce in pharma rankings ahead of hybrid CPhI & P-MEC China

Pharma Mirror

Shanghai, China’s pharma industry has seen a record improvement in its overall score, growth potential and biologics according to new data. The China specific findings of the CPhI Annual Report rankings[1] are released ahead of CPhI & P-MEC China – which will take place in hybrid form, with Virtual Expo Connect running digitally from November 18th until December 18th, and the in-person event held at the Shanghai New International Expo Center (SNIEC) December 16-18th, 2021.

52
article thumbnail

EC approves Celltrion’s COVID-19 mAb Regkirona

Pharma Times

Treatment authorised for use in adults with COVID-19 who are at high-risk of progressing to severe disease

54
article thumbnail

Novo Nordisk on seeking partnerships to expand its portfolio

pharmaphorum

Its vast experience in diabetes and the amount of data collected has propelled Novo Nordisk into exploring new modalities and searching for valuable collaborators, according to the company’s senior VP of global drug discovery Karin Conde-Knape. She discusses which therapeutic areas the company is gaining momentum in and how it aims to build its presence within these areas through external partnerships, in a session at the recent BIO-Europe with pharmaphorum’s founder Paul Tunnah.

98
article thumbnail

Biden admin finalizes rule that requires insurers to submit data on drug costs, rebates

Fierce Healthcare

Biden admin finalizes rule that requires insurers to submit data on drug costs, rebates. pminemyer. Wed, 11/17/2021 - 16:42.

Insurance 136
article thumbnail

Tech Innovations: November 2021

Outsourcing Pharma

This monthâs launches, expanded facilities, partnerships, and other news includes items from Veeva, Hovione, Florence, Medidata, and other notable firms.

52
article thumbnail

JCVI advises extending COVID-19 booster programme

Pharma Times

All adults aged 40- to 49-years-old to be offered an mRNA vaccine booster dose

article thumbnail

AI specialist Owkin snares $270m alliance with Sanofi in oncology

pharmaphorum

Sanofi has made another investment in artificial intelligence, taking a $180 million equity stake in Franco-US startup Owkin with another $90 million in funding for a program to seek out new cancer therapies. The three-year project will focus on four types of cancer, and will deploy Owkin’s predictive biomedical AI models to find new biomarkers and therapeutic targets, as well as building models of the cancers and methods to predict if a patient will respond to a particular treatment.

article thumbnail

Avalere: Providers face 40% hit to Part B reimbursements under Dem drug price reforms

Fierce Healthcare

Avalere: Providers face 40% hit to Part B reimbursements under Dem drug price reforms. rking. Fri, 11/19/2021 - 15:04.

135
135